The ability to adjust skin darkness to the background is a common phenomenon in fish. The hormone a-melanophore stimulating hormone (aMSH) enhances skin darkening. In Mozambique tilapia, Oreochromis mossambicus L., aMSH acts as a corticotropic hormone during adaptation to water with a low pH, in addition to its role in skin colouration. In the current study, we investigated the responses of this fish to these two environmental challenges when it is exposed to both simultaneously. The skin darkening of tilapia on a black background and the lightening on grey and white backgrounds is compromised in water with a low pH, indicating that the two vastly different processes both rely on aMSH -regulatory mechanisms.If the water is acidified after 25 days of undisturbed background adaptation, fish showed a transient pigmentation change but recovered after two days and continued the adaptation of their skin darkness to match the background. Black backgrounds are experienced by tilapia as more stressful than grey or white backgrounds both in neutral and in low pH water. A decrease of water pH from 7.8 to 4.5 applied over a twoday period was not experienced as stressful when combined with background adaptation, based on unchanged plasma pH and plasma aMSH and Na levels. However, when water pH was lowered after 25 days of undisturbed background adaptation, particularly aMSH levels increased chronically. In these fish, plasma pH and Na levels had decreased, indicating a reduced capacity to maintain ion-homeostasis, implicating that the fish indeed experience stress. We conclude that simultaneous exposure to these two types of stressor has a lower impact on the physiology of tilapia than subsequent exposure to the stressors.
* Cover Letter
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.